Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy

Heather D. VanGuilder, Georgina V. Bixler, Lydia Kutzler, Robert M. Brucklacher, Sarah K. Bronson, Scot R. Kimball, Willard M. Freeman

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: As a leading cause of adult blindness, diabetic retinopathy is a prevalent and profound complication of diabetes. We have previously reported duration-dependent changes in retinal vascular permeability, apoptosis, and mRNA expression with diabetes in a rat model system. The aim of this study was to identify retinal proteomic alterations associated with functional dysregulation of the diabetic retina to better understand diabetic retinopathy pathogenesis and that could be used as surrogate endpoints in preclinical drug testing studies. Methodology/Principal Findings: A multi-modal proteomic approach of antibody (Luminex)-, electrophoresis (DIGE)-, and LC-MS (iTRAQ)-based quantitation methods was used to maximize coverage of the retinal proteome. Transcriptomic profiling through microarray analysis was included to identify additional targets and assess potential regulation of protein expression changes at the mRNA level. The proteomic approaches proved complementary, with limited overlap in proteomic coverage. Alterations in pro-inflammatory, signaling and crystallin family proteins were confirmed by orthogonal methods in multiple independent animal cohorts. In an independent experiment, insulin replacement therapy normalized the expression of some proteins (Dbi, Anxa5) while other proteins (Cp, Cryba3, Lgals3, Stat3) were only partially normalized and Fgf2 and Crybb2 expression remained elevated. Conclusions/Significance: These results expand the understanding of the changes in retinal protein expression occurring with diabetes and their responsiveness to normalization of blood glucose through insulin therapy. These proteins, especially those not normalized by insulin therapy, may also be useful in preclinical drug development studies.

Original languageEnglish (US)
Article numbere16271
JournalPloS one
Volume6
Issue number1
DOIs
StatePublished - Feb 1 2011

Fingerprint

diabetic retinopathy
Diabetic Retinopathy
Proteomics
proteomics
Rats
protein synthesis
animal models
diabetes
Medical problems
Proteins
Insulin
crystallins
drugs
proteins
blindness
proteome
endpoints
transcriptomics
retina
blood vessels

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

VanGuilder, Heather D. ; Bixler, Georgina V. ; Kutzler, Lydia ; Brucklacher, Robert M. ; Bronson, Sarah K. ; Kimball, Scot R. ; Freeman, Willard M. / Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy. In: PloS one. 2011 ; Vol. 6, No. 1.
@article{16e8fd679a4f42b6b6b9febaea61cf35,
title = "Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy",
abstract = "Background: As a leading cause of adult blindness, diabetic retinopathy is a prevalent and profound complication of diabetes. We have previously reported duration-dependent changes in retinal vascular permeability, apoptosis, and mRNA expression with diabetes in a rat model system. The aim of this study was to identify retinal proteomic alterations associated with functional dysregulation of the diabetic retina to better understand diabetic retinopathy pathogenesis and that could be used as surrogate endpoints in preclinical drug testing studies. Methodology/Principal Findings: A multi-modal proteomic approach of antibody (Luminex)-, electrophoresis (DIGE)-, and LC-MS (iTRAQ)-based quantitation methods was used to maximize coverage of the retinal proteome. Transcriptomic profiling through microarray analysis was included to identify additional targets and assess potential regulation of protein expression changes at the mRNA level. The proteomic approaches proved complementary, with limited overlap in proteomic coverage. Alterations in pro-inflammatory, signaling and crystallin family proteins were confirmed by orthogonal methods in multiple independent animal cohorts. In an independent experiment, insulin replacement therapy normalized the expression of some proteins (Dbi, Anxa5) while other proteins (Cp, Cryba3, Lgals3, Stat3) were only partially normalized and Fgf2 and Crybb2 expression remained elevated. Conclusions/Significance: These results expand the understanding of the changes in retinal protein expression occurring with diabetes and their responsiveness to normalization of blood glucose through insulin therapy. These proteins, especially those not normalized by insulin therapy, may also be useful in preclinical drug development studies.",
author = "VanGuilder, {Heather D.} and Bixler, {Georgina V.} and Lydia Kutzler and Brucklacher, {Robert M.} and Bronson, {Sarah K.} and Kimball, {Scot R.} and Freeman, {Willard M.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1371/journal.pone.0016271",
language = "English (US)",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy. / VanGuilder, Heather D.; Bixler, Georgina V.; Kutzler, Lydia; Brucklacher, Robert M.; Bronson, Sarah K.; Kimball, Scot R.; Freeman, Willard M.

In: PloS one, Vol. 6, No. 1, e16271, 01.02.2011.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy

AU - VanGuilder, Heather D.

AU - Bixler, Georgina V.

AU - Kutzler, Lydia

AU - Brucklacher, Robert M.

AU - Bronson, Sarah K.

AU - Kimball, Scot R.

AU - Freeman, Willard M.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Background: As a leading cause of adult blindness, diabetic retinopathy is a prevalent and profound complication of diabetes. We have previously reported duration-dependent changes in retinal vascular permeability, apoptosis, and mRNA expression with diabetes in a rat model system. The aim of this study was to identify retinal proteomic alterations associated with functional dysregulation of the diabetic retina to better understand diabetic retinopathy pathogenesis and that could be used as surrogate endpoints in preclinical drug testing studies. Methodology/Principal Findings: A multi-modal proteomic approach of antibody (Luminex)-, electrophoresis (DIGE)-, and LC-MS (iTRAQ)-based quantitation methods was used to maximize coverage of the retinal proteome. Transcriptomic profiling through microarray analysis was included to identify additional targets and assess potential regulation of protein expression changes at the mRNA level. The proteomic approaches proved complementary, with limited overlap in proteomic coverage. Alterations in pro-inflammatory, signaling and crystallin family proteins were confirmed by orthogonal methods in multiple independent animal cohorts. In an independent experiment, insulin replacement therapy normalized the expression of some proteins (Dbi, Anxa5) while other proteins (Cp, Cryba3, Lgals3, Stat3) were only partially normalized and Fgf2 and Crybb2 expression remained elevated. Conclusions/Significance: These results expand the understanding of the changes in retinal protein expression occurring with diabetes and their responsiveness to normalization of blood glucose through insulin therapy. These proteins, especially those not normalized by insulin therapy, may also be useful in preclinical drug development studies.

AB - Background: As a leading cause of adult blindness, diabetic retinopathy is a prevalent and profound complication of diabetes. We have previously reported duration-dependent changes in retinal vascular permeability, apoptosis, and mRNA expression with diabetes in a rat model system. The aim of this study was to identify retinal proteomic alterations associated with functional dysregulation of the diabetic retina to better understand diabetic retinopathy pathogenesis and that could be used as surrogate endpoints in preclinical drug testing studies. Methodology/Principal Findings: A multi-modal proteomic approach of antibody (Luminex)-, electrophoresis (DIGE)-, and LC-MS (iTRAQ)-based quantitation methods was used to maximize coverage of the retinal proteome. Transcriptomic profiling through microarray analysis was included to identify additional targets and assess potential regulation of protein expression changes at the mRNA level. The proteomic approaches proved complementary, with limited overlap in proteomic coverage. Alterations in pro-inflammatory, signaling and crystallin family proteins were confirmed by orthogonal methods in multiple independent animal cohorts. In an independent experiment, insulin replacement therapy normalized the expression of some proteins (Dbi, Anxa5) while other proteins (Cp, Cryba3, Lgals3, Stat3) were only partially normalized and Fgf2 and Crybb2 expression remained elevated. Conclusions/Significance: These results expand the understanding of the changes in retinal protein expression occurring with diabetes and their responsiveness to normalization of blood glucose through insulin therapy. These proteins, especially those not normalized by insulin therapy, may also be useful in preclinical drug development studies.

UR - http://www.scopus.com/inward/record.url?scp=79251579038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251579038&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0016271

DO - 10.1371/journal.pone.0016271

M3 - Article

C2 - 21249158

AN - SCOPUS:79251579038

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e16271

ER -